JOHNSON & JOHNSON (JNJ) Stock Analyst Ratings
USA - NYSE:JNJ - US4781601046 - Common Stock
203.9 USD
+0.83 (+0.41%)
204.2 USD
+0.3 (+0.15%)
ChartMill assigns a Buy % Consensus number of 75% to JNJ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 204.02. This target is 0.06% above the current price.
JNJ was analyzed by 31 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about JNJ.
In the previous month the buy percentage consensus was at a similar level.
JNJ was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-22 | Freedom Capital Markets | Downgrade | Buy -> Hold |
| 2025-10-15 | Stifel | Maintains | Hold -> Hold |
| 2025-10-15 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-15 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-15 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-14 | UBS | Maintains | Buy -> Buy |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-09 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-06 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2025-10-03 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-03 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-23 | Guggenheim | Upgrade | Neutral -> Buy |
| 2025-09-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-17 | Guggenheim | Maintains | Neutral -> Neutral |
| 2025-07-17 | UBS | Maintains | Buy -> Buy |
| 2025-07-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-17 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-17 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-07-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-13 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-04-17 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-16 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-04-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-14 | Raymond James | Maintains | Outperform -> Outperform |
JOHNSON & JOHNSON / JNJ FAQ
Can you provide the average price target for JOHNSON & JOHNSON stock?
31 analysts have analysed JNJ and the average price target is 204.02 USD. This implies a price increase of 0.06% is expected in the next year compared to the current price of 203.9.
Can you provide the consensus rating for JOHNSON & JOHNSON stock?
The consensus rating for JOHNSON & JOHNSON (JNJ) is 75.4839 / 100 . This indicates that analysts generally have a positive outlook on the stock.